Price$48.23-2.26 (-4.48%)
01:30 PM07:45 PM
News · 26 weeks66-78%
2026-04-192026-10-11
Mix3490d
- Insider22(65%)
- Other4(12%)
- SEC Filings4(12%)
- Earnings2(6%)
- Analyst2(6%)
Latest news
25 items- INSIDERSEC Form 4 filed by Heartflow Inc.4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Medical Officer Rogers Campbell exercised 13,179 shares at a strike of $7.94 and sold $987,052 worth of shares (19,682 units at $50.15) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 79,956 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Financial Officer Verghese Vikram sold $1,230,742 worth of Common Stock. (24,345 units at $50.55) as part of a pre-agreed trading plan, decreasing direct ownership by 14% to 155,183 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Financial Officer Verghese Vikram sold $1,751,611 worth of Common Stock. (34,975 units at $50.08) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 179,528 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. sold $1,819,605 worth of shares (38,900 units at $46.78) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 321,914 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Financial Officer Verghese Vikram sold $332,212 worth of Common Stock. (6,640 units at $50.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 214,503 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- ANALYSTUBS resumed coverage on Heartflow with a new price targetUBS resumed coverage of Heartflow with a rating of Neutral and set a new price target of $55.00
- INSIDERChief Financial Officer Verghese Vikram sold $1,665,796 worth of Common Stock. (33,416 units at $49.85) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 221,143 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- PRLate Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly HalfSAN FRANCISCO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced late-breaking one-year results from an independent randomized clinical trial proving the Heartflow FFRCT Analysis safely and significantly reduced unnecessary invasive heart procedures by 44% (p < 0.001). Presented as Late-Breaking Science at the European Society of Cardiology (ESC) Congress 2026, FUSION trial, funded by the Dutch National Health Care Institute, demonstrates that standard coronary computed tomography angiography (CCTA) alone drives overutilization of invasive catheterizations.1 By
- PRHeartflow to Participate in the Wells Fargo 21st Annual Healthcare ConferenceSAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer session, will take place in Boston on Wednesday, September 9, 2026, at 3:45 p.m. ET / 12:45 p.m. PT. A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com. About Heartflow’s Tech
- INSIDERChief Executive Officer Farquhar John C.M. sold $1,361,500 worth of shares (27,230 units at $50.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 360,814 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. sold $1,470,420 worth of shares (32,676 units at $45.00) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 388,044 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Medical Officer Rogers Campbell exercised 9,219 shares at a strike of $19.00 and sold $380,099 worth of shares (9,219 units at $41.23) as part of a pre-agreed trading plan (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. sold $607,774 worth of shares (15,560 units at $39.06) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 420,720 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- SECSEC Form 144 filed by Heartflow Inc.144 - Heartflow, Inc. (0001464521) (Subject)
- SECSEC Form 144 filed by Heartflow Inc.144 - Heartflow, Inc. (0001464521) (Subject)
- SECSEC Form 10-Q filed by Heartflow Inc.10-Q - Heartflow, Inc. (0001464521) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Heartflow Inc.SCHEDULE 13G/A - Heartflow, Inc. (0001464521) (Subject)
- SECHeartflow Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Heartflow, Inc. (0001464521) (Filer)
- PRHeartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceSAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights Total revenue of $64.1 million, a 48% increase year-over-yearGross margin of 83.0%, non-GAAP gross margin of 83.3%Net operating loss of $17.9 million; non-GAAP net operating loss of $7.9 million 2026 Annual Guidance Total revenue of $246 million to $250 million (approximately 40% to 42% growth year-over-year), compared to previous guidance of $228 million to $232 million (approximately 29% to 32% growth year-
- INSIDERChief Executive Officer Farquhar John C.M. sold $638,730 worth of shares (22,562 units at $28.31) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 436,280 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Accounting Officer Jones Marie L. was granted 1,661 units of Common Stock. and covered exercise/tax liability with 568 units of Common Stock., increasing direct ownership by 2% to 32,176 units (SEC Form 4) to cover taxes4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Financial Officer Verghese Vikram was granted 671 units of Common Stock. and covered exercise/tax liability with 2,010 units of Common Stock., increasing direct ownership by 20% to 254,559 units (SEC Form 4) to cover withholding tax4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Medical Officer Rogers Campbell covered exercise/tax liability with 2,272 shares, decreasing direct ownership by 3% to 86,459 units (SEC Form 4) (withholding tax)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. covered exercise/tax liability with 7,751 shares, decreasing direct ownership by 2% to 458,842 units (SEC Form 4) (withholding tax)4 - Heartflow, Inc. (0001464521) (Issuer)
HTFL FAQ
6 questionsWhere does HTFL stock trade?
Heartflow Inc. (HTFL) is listed on NASDAQ.What sector and industry is HTFL in?
Heartflow Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Heartflow Inc. go public?
Heartflow Inc. (HTFL) completed its IPO in 2025.What are analysts saying about HTFL?
Heartflow Inc. has had 8 recent analyst actions on file. The most recent action was from UBS: Neutral on 2026-09-09. Recent price targets range from $3400.00 to $3800.00.What companies are similar to HTFL?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare HTFL side-by-side with any of them on Quantisnow.How can I track HTFL on Quantisnow?
Quantisnow aggregates Heartflow Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HTFL to receive live email and push alerts on every new disclosure.